Bladder Cancer - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Bladder Cancer

- Cancer PHGKB -

What's New

Last Posted: Aug 29, 2019

---

• SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018). 
  Gonz?lez Del Alba A et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2019 Jan 21(1) 64-74
• Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology. 
  Dyrskjøt Lars et al. Current opinion in urology 2018 28(6) 598-603
• Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer? 
  Grossman H Barton et al. European urology oncology 2019 Jul
• Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes. 
  Mitchell Khadijah A et al. Urologic oncology 2019 Jun
• Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer. 
  Han Yuying et al. Journal of surgical oncology 2019 Jun 119(8) 1145-1154
• Bladder cancer: Multi-omic profiling refines the molecular view. 
  Hurst Carolyn D et al. Nature reviews. Clinical oncology 2018 15(4) 203-204
• Identification of Hub Genes Associated With Progression and Prognosis in Patients With Bladder Cancer. 
  Yan Xin et al. Frontiers in genetics 2019 10408
• Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma. 
  Eich Marie-Lisa et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2019 Apr
• Hope and challenge: Precision medicine in bladder cancer. 
  Su Hongwei et al. Cancer medicine 2019 Mar
• Interest of next-generation sequencing in BCG-treated high-risk bladder cancer. 
  Jungels C et al. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 2018 May 28(6) 344-350
• Clinical and Genomic Considerations for Variant Histology in Bladder Cancer. 
  Matulay Justin T et al. Current oncology reports 2019 Feb 21(3) 23
• Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients. 
  Montalbo Ruth et al. Translational research : the journal of laboratory and clinical medicine 2019 Feb
• Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy. 
  van Kessel Kim E M et al. The Journal of urology 2017 197(3 Pt 1) 590-595
• Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer. 
  Meric-Bernstam Funda et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Nov
• Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria. 
  Xu Yanjie et al. Urologic oncology 2018 Nov